Advisory Services Network’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Sell
74,137
-4,688
-6% -$656K 0.14% 151
2025
Q4
$9.68M Sell
78,825
-3,099
-4% -$377K 0.14% 157
2025
Q3
$9.09M Sell
81,924
-6,430
-7% -$731K 0.13% 166
2025
Q2
$9.92M Buy
88,354
+98
+0.1% +$10.4K 0.16% 137
2025
Q1
$9.89M Buy
88,256
+17,169
+24% +$1.77M 0.19% 112
2024
Q4
$6.57M Buy
71,087
+8,970
+14% +$808K 0.12% 181
2024
Q3
$4.26M Hold
62,117
0.09% 248
2024
Q2
$4.26M Sell
62,117
-12,430
-17% -$830K 0.09% 248
2024
Q1
$5.46M Sell
74,547
-887
-1% -$68.2K 0.12% 193
2023
Q4
$6.11M Sell
75,434
-11,690
-13% -$910K 0.15% 149
2023
Q3
$6.53M Buy
87,124
+8,283
+11% +$637K 0.18% 126
2023
Q2
$6.08M Sell
78,841
-3,702
-4% -$295K 0.16% 135
2023
Q1
$6.85M Sell
82,543
-9,917
-11% -$821K 0.19% 117
2022
Q4
$7.94M Sell
92,460
-10,009
-10% -$793K 0.24% 89
2022
Q3
$6.32M Buy
102,469
+9,431
+10% +$595K 0.22% 99
2022
Q2
$5.75M Sell
93,038
-1,222
-1% -$75.7K 0.2% 121
2022
Q1
$5.6M Buy
94,260
+10,949
+13% +$700K 0.16% 144
2021
Q4
$6.05M Buy
83,311
+985
+1% +$67.8K 0.17% 134
2021
Q3
$5.75M Buy
82,326
+12,557
+18% +$882K 0.18% 131
2021
Q2
$4.8M Buy
69,769
+2,926
+4% +$195K 0.15% 168
2021
Q1
$4.32M Buy
66,843
+25,201
+61% +$1.62M 0.16% 158
2020
Q4
$2.43M Sell
41,642
-3,350
-7% -$202K 0.1% 244
2020
Q3
$2.84M Sell
44,992
-4,666
-9% -$324K 0.13% 182
2020
Q2
$3.82M Sell
49,658
-24,121
-33% -$1.85M 0.21% 125
2020
Q1
$5.52M Buy
73,779
+33,587
+84% +$2.32M 0.36% 57
2019
Q4
$2.61M Buy
40,192
+1,082
+3% +$70.5K 0.14% 186
2019
Q3
$2.64M Hold
39,110
0.16% 160
2019
Q2
$2.64M Buy
39,110
+5,959
+18% +$392K 0.16% 160
2019
Q1
$2.15M Buy
33,151
+2,712
+9% +$180K 0.15% 180
2018
Q4
$1.9M Sell
30,439
-3,083
-9% -$215K 0.17% 154
2018
Q3
$2.59M Sell
33,522
-3,744
-10% -$283K 0.19% 131
2018
Q2
$2.91M Buy
37,266
+7,850
+27% +$554K 0.22% 116
2018
Q1
$2.22M Buy
29,416
+13,986
+91% +$1.11M 0.18% 138
2017
Q4
$1.1M Sell
15,430
-3,315
-18% -$252K 0.1% 287
2017
Q3
$1.52M Sell
18,745
-362
-2% -$27.7K 0.17% 149
2017
Q2
$1.35M Sell
19,107
-2,481
-11% -$165K 0.18% 149
2017
Q1
$1.47M Buy
+21,588
New +$1.52M 0.21% 107
2016
Q3
$2.94M Buy
37,128
+2,605
+8% +$212K 0.55% 28
2016
Q2
$2.88M Sell
34,523
-3,439
-9% -$305K 0.65% 20
2016
Q1
$3.49M Buy
37,962
+784
+2% +$70.7K 0.95% 10
2015
Q4
$3.76M Buy
37,178
+3,235
+10% +$337K 1.21% 9
2015
Q3
$3.33M Sell
33,943
-671
-2% -$74.5K 1.01% 15
2015
Q2
$4.02M Buy
34,614
+133
+0.4% +$14.5K 1.19% 12
2015
Q1
$3.37M Sell
34,481
-15,134
-31% -$1.54M 0.93% 16
2014
Q4
$5.15M Buy
49,615
+11,172
+29% +$1.16M 1.61% 9
2014
Q3
$4.09M Buy
38,443
+6,713
+21% +$657K 1.5% 11
2014
Q2
$2.63M Buy
31,730
+2,067
+7% +$161K 1.11% 18
2014
Q1
$2.1M Buy
29,663
+7,462
+34% +$585K 1.08% 18
2013
Q4
$1.67M Buy
22,201
+7,561
+52% +$526K 0.84% 27
2013
Q3
$920K Buy
14,640
+3,164
+28% +$189K 0.79% 41
2013
Q2
$624K Buy
+11,476
New +$598K 0.51% 51

Other funds holding GILD

Advisory Services Network's GILD Position: Q1 2026 in Review

Advisory Services Network reduced its Gilead Sciences (GILD) stake by 5.9% in Q1 2026, selling an estimated $656K and leaving 74,137 shares worth $10.3M. The position accounts for 0.14% of the portfolio, ranked #151.

Advisory Services Network first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Advisory Services Network held 74,137 shares of Gilead Sciences worth $10.3M as of Q1 2026.
  • Advisory Services Network sold 4,688 Gilead Sciences shares in Q1 2026, an estimated $656K.
  • Gilead Sciences made up 0.14% of Advisory Services Network's portfolio in Q1 2026, its #151 holding.
  • Advisory Services Network first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.